Dr Hazel Squires
BSc (91Ö±²¥), MSc (Lancaster), PhD (91Ö±²¥)
Population Health, School of Medicine and Population Health
Senior Research Fellow
+44 114 222 0765
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91Ö±²¥
S1 4DA
- Profile
-
I joined ScHARR in 2005 after completing a BSc in Mathematics from the University of 91Ö±²¥ and an MSc in Operational Research from Lancaster University. Since joining ScHARR, I have undertaken modelling projects for NICE, the Department of Health, the NHS Cancer Screening Programme and the pharmaceutical industry. A large part of this work has been around Public Health interventions and cancer screening, diagnosis and treatment. In 2010 - 2013 I developed a framework for helping modellers develop the structure of Public Health economic models as part of a NIHR doctoral research fellowship.
I am currently undertaking a NIHR Advanced Fellowship, exploring methods for incorporating behaviour into health economic models of Public Health interventions.
I contribute to PhD and Masters programmes in ScHARR including being one of the Directors of the Wellcome Doctoral Training Centre in Public Health Economics and Decision Science () and module lead of Advanced Simulation Methods (/scharr/modules/har672-advanced-simulation-methods)
- Research interests
-
- Healthcare modelling
- Modelling within public health
- Conceptual modelling
- Individual-level simulation to model healthcare systems
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Health Economics.
- . Public Health, 194, 263-269.
- . BMC Public Health, 21.
- . Health technology assessment, 21(68).
- . Diabetic Medicine, 34(5), 632-640.
- . Value in Health, 19(5), 588-601.
- . PharmacoEconomics, 34(7), 673-680.
- . International Journal of Public Health, 61(3), 289-298.
- . Appl Health Econ Health Policy, 12(3), 239-253.
- . International Journal of Systems Science, 45(1), 60-68.
- . J Public Health (Oxf), 34(1), 115-124.
- . Health Technol Assess, 15(40), 1-210.
- . Clinical Therapeutics, 33(9), 1289-1305.
- . J OPER RES SOC, 60(10), 1305-1314.
- Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 13(10).
- . J OPER RES SOC, 59(7), 902-910.
- . Health Economics.
All publications
Journal articles
- . Nicotine and Tobacco Research, ntae225.
- . BMC Public Health, 24(1).
- . Value in Health.
- . Health Economics.
- . BMC Geriatrics, 23(1).
- . Cost Effectiveness and Resource Allocation, 20(1).
- . BMC Health Services Research, 22(1).
- . BMC Health Services Research, 22(1).
- . BMC Health Services Research, 21(1).
- . Public Health, 194, 263-269.
- . BMC Public Health, 21.
- . British Journal of Ophthalmology.
- . British Journal of Ophthalmology.
- . PharmacoEconomics.
- . PharmacoEconomics, 36(1), 29-38.
- . Health technology assessment, 21(68).
- . Journal of Epidemiology and Community Health, 71, 897-904.
- . BMJ Open, 7.
- . Diabetic Medicine, 34(8), 1136-1144.
- . Diabetic Medicine, 34(5), 632-640.
- . J Public Health (Oxf), 38(4), 679-687.
- . Value in Health, 19(5), 588-601.
- . PharmacoEconomics, 34(7), 673-680.
- . International Journal of Public Health, 61(3), 289-298.
- . Diabetic Medicine, 33(8), 1155-1163.
- . Appl Health Econ Health Policy, 12(3), 239-253.
- . Angiology, 65(3), 190-197.
- . International Journal of Systems Science, 45(1), 60-68.
- . Br J Surg, 100(13), 1838-1839.
- . Value in Health.
- . Value Health, 15(8), 1127-1136.
- . The Lancet, 380, S68-S68.
- . British Journal of Surgery, 99(12), 1630-1638.
- . PLoS ONE, 7(2).
- . J Public Health (Oxf), 34(1), 115-124.
- . Health Technol Assess, 15(40), 1-210.
- . Clinical Therapeutics, 33(9), 1289-1305.
- . J Fam Plann Reprod Health Care, 37(2), 71-84.
- . Eur J Contracept Reprod Health Care, 16(3), 149-160.
- . Value in Health, 14(5), 768-776.
- . Colorectal Dis, 13(10), 1085-1099.
- . Int J Technol Assess Health Care, 26(4), 362-369.
- . Health Technol Assess, 14(32), 1-206.
- . J Pediatr Adolesc Gynecol, 23(6), 341-351.
- . CLIN THER, 32(5), 789-803.
- . Aliment Pharmacol Ther, 31(7), 708-718.
- . International Journal of Technology Assessment in Health Care, 26(4), 362-369.
- . Disabil Rehabil, 32(8), 607-621.
- . Journal of Pediatric and Adolescent Gynecology.
- . J OPER RES SOC, 60(10), 1305-1314.
- . Int J Technol Assess Health Care, 25(4), 470-478.
- . Health Technol Assess, 13 Suppl 1, 1-6.
- . Health Technol Assess, 13(10), iii-103.
- Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 13(10).
- Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 13(10).
- . J OPER RES SOC, 59(7), 902-910.
- . BJOG-INT J OBSTET GY, 115(6), 749-757.
- . Blood, 110(11), 5175-5175.
- Questions about adjuvant trastuzamab still remain (vol 369, pg 3, 2007). LANCET, 369(9562), 642-642.
- . Lancet, 369(9555), 3-5.
- . BMC Public Health, 24(1).
- . BMC Geriatrics, 24(1).
- . Emergency Medicine Journal.
- . Health Economics.
- . Wellcome Open Research, 7, 7-7.
- . Wellcome Open Research, 7, 7-7.
- . Health Technology Assessment, 13(Suppl 1), 1-6.
- What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open.
Conference proceedings papers
- . Value in Health, Vol. 17(7) (pp A556-A556)
- . Value in Health, Vol. 17(7) (pp A347-A347)
- . VALUE IN HEALTH, Vol. 15(7) (pp A633-A633)
- COST-EFFECTIVENESS ANALYSIS OF NILOTINIB VERSES IMATINIB FOR THE TREATMENT OF CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKAEMIA. HAEMATOLOGICA, Vol. 97 (pp 314-314)
- . VALUE IN HEALTH, Vol. 14(7) (pp A243-A243)
- . VALUE IN HEALTH, Vol. 14(7) (pp A469-A470)
- A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 141 (pp 38-38)
- A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib.. BLOOD, Vol. 110(11) (pp 376B-376B)
- Incorporating the COM-B model for behavior change into an agent-based model of smoking behaviors: an object-oriented design. Proceedings of the 2024 Winter Simulation Conference. Orlando, Florida, 15 December 2024 - 15 December 2024.
Posters
- Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and followup of colorectal cancer.
Datasets
Other
Preprints
- Teaching interests
-
My teaching interests are:
- Mathematical modelling within healthcare
- Discrete event simulation
- Professional activities and memberships
-
- Editorial Board of Journal of Simulation
- I am a member of the Operational Research Society.